Drugs / IDP-120 Component B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02537483 Comparator | Oct 2015 → Sep 2016 | acne | Valeant Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDP-120 Component B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02537483 ↗ |
| Route | Topical | “IDP-120 Component B, applied topically to the face once daily for 12 weeks” NCT02537483 ↗ |